TCS is a type I ribosome-inactivating protein, which has high anti-tumor activity through the mechanism of ribosome inactivation and apoptosis, while ABZ is a β-tubulin inhibitor, which shows strong anti-tumor activity. This evidence concerns the gene TCOF1 and neoplasm.